CoreCap Advisors’s Smith & Wesson SWBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-350
Closed -$5.02K 3277
2026
Q1
$5.02K Hold
350
﹤0.01% 2171
2025
Q4
$3.46K Hold
350
﹤0.01% 2329
2025
Q3
$3.44K Sell
350
-1,750
-83% -$14.9K ﹤0.01% 2273
2025
Q2
$18.2K Buy
2,100
+1,750
+500% +$16.6K ﹤0.01% 1651
2025
Q1
$3.26K Buy
350
+100
+40% +$1.03K ﹤0.01% 2215
2024
Q4
$2.53K Hold
250
﹤0.01% 2165
2024
Q3
$3.25K Buy
+250
New +$3.61K ﹤0.01% 2082
2024
Q2
Sell
-50
Closed -$868 2462
2024
Q1
$868 Buy
+50
New +$721 ﹤0.01% 2247
2022
Q4
$434 Buy
+50
New +$527 ﹤0.01% 2189
2022
Q3
Sell
-50
Closed -$1K 1898
2022
Q2
$1K Buy
+50
New +$725 ﹤0.01% 2062
2022
Q1
Sell
-1,125
Closed -$20K 1902
2021
Q4
$20K Buy
+1,125
New +$23.2K ﹤0.01% 1331

Other funds holding SWBI

CoreCap Advisors's SWBI Position: Q2 2026 in Review

CoreCap Advisors sold out of Smith & Wesson (SWBI) in Q2 2026, closing a stake of 350 shares — an estimated $5.02K sold.

CoreCap Advisors first reported a position in SWBI in Q4 2021 and held it in 11 quarters. The position peaked at $20K in Q4 2021. 200 funds tracked by Wall St. Rank hold SWBI as of Q2 2026.

  • CoreCap Advisors reported no remaining Smith & Wesson position as of Q2 2026 after selling out during the quarter.
  • CoreCap Advisors sold 350 Smith & Wesson shares in Q2 2026, an estimated $5.02K.
  • CoreCap Advisors first reported a position in Smith & Wesson in Q4 2021 and held it in 11 quarters.
  • CoreCap Advisors's Smith & Wesson position peaked at $20K in Q4 2021.
  • 200 funds tracked by Wall St. Rank held Smith & Wesson as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.